PPH
VanEck Pharmaceutical ETF Equity$102.23
-0.36%
(-0.37)
AUM $948.1M
Expense 36.00%
52w Low $81.74
66.4% of range
52w High $112.58
50d MA $104.00
200d MA $98.24
NAV
$102.08
AUM
$948.1M
Expense
36.00%
Holdings
26
Avg Volume
350K
Inception
Dec 20, 2011
Issuer
VanEck
Exchange
—
Domicile
US
ISIN
US92189F6925
50d MA
$104.00
200d MA
$98.24
About
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Sector Exposure
Healthcare
100.0%
Industrials
0.1%
Cash & Others
-0.0%
Top Holdings
| Ticker | Name | Weight |
|---|---|---|
| LLY | Eli Lilly & Co | 19.97% |
| NVS | Novartis Ag | 10.40% |
| MRK | Merck & Co Inc | 9.29% |
| NVO | Novo Nordisk A/S | 5.90% |
| PFE | Pfizer Inc | 4.97% |
| BMY | Bristol-Myers Squibb Co | 4.46% |
| SNY | Sanofi Sa/France | 4.32% |
| GSK | Gsk Plc | 4.31% |
| AZN | Astrazeneca Plc | 4.15% |
| JNJ | Johnson & Johnson | 4.06% |
| MCK | Mckesson Corp | 4.04% |
| ABBV | Abbvie Inc | 4.00% |
| COR | Cencora Inc | 3.67% |
| TEVA | Teva Pharmaceutical Industries Ltd | 3.37% |
| ZTS | Zoetis Inc | 3.36% |